Medicare Part D has performed very well, PhRMA told the Senate Aging Committee during a hearing Wednesday. "Since the program’s inception, Medicare Part D has succeeded for seniors and disabled beneficiaries and for taxpayers, significantly improving access to medicines while helping control other health costs," said Richard Smith, PhRMA's executive vice president of policy and research.

Full Story:
Hill, The

Related Summaries